New York State Teachers Retirement System lessened its holdings in shares of Gentex Co. (NASDAQ:GNTX – Free Report) by 9.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 226,471 shares of the auto parts company’s stock after selling 22,700 shares during the period. New York State Teachers Retirement System owned approximately 0.10% of Gentex worth $6,724,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of GNTX. Wealth Enhancement Advisory Services LLC increased its stake in Gentex by 38.6% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 26,750 shares of the auto parts company’s stock valued at $966,000 after purchasing an additional 7,449 shares in the last quarter. Private Advisor Group LLC grew its position in shares of Gentex by 3.7% in the first quarter. Private Advisor Group LLC now owns 19,768 shares of the auto parts company’s stock valued at $714,000 after purchasing an additional 704 shares during the last quarter. Central Pacific Bank Trust Division purchased a new position in shares of Gentex during the 1st quarter worth approximately $196,000. GSA Capital Partners LLP acquired a new position in shares of Gentex during the 1st quarter worth approximately $842,000. Finally, Chevy Chase Trust Holdings LLC grew its holdings in Gentex by 1.3% during the 1st quarter. Chevy Chase Trust Holdings LLC now owns 83,695 shares of the auto parts company’s stock valued at $3,023,000 after buying an additional 1,048 shares during the last quarter. Institutional investors and hedge funds own 86.76% of the company’s stock.
Insider Buying and Selling at Gentex
In other Gentex news, major shareholder Corp Gentex purchased 3,152,500 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was acquired at an average cost of $5.00 per share, with a total value of $15,762,500.00. Following the acquisition, the insider now owns 6,463,808 shares of the company’s stock, valued at approximately $32,319,040. This represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.41% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on Gentex
Gentex Stock Performance
NASDAQ:GNTX opened at $30.09 on Tuesday. The company has a market capitalization of $6.93 billion, a price-to-earnings ratio of 16.09, a price-to-earnings-growth ratio of 0.98 and a beta of 0.91. Gentex Co. has a one year low of $28.30 and a one year high of $37.58. The stock has a 50-day simple moving average of $29.95 and a 200 day simple moving average of $32.04.
Gentex Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Wednesday, October 9th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Wednesday, October 9th. Gentex’s dividend payout ratio is presently 25.67%.
Gentex Profile
Gentex Corporation designs, develops, manufactures, markets, and supplies digital vision, connected car, dimmable glass, and fire protection products in the United States, Germany, Japan, Mexico, Republic of Korea, and internationally. It operates through Automotive Products and Other segments. The company offers automotive products, including interior and exterior electrochromic automatic-dimming rearview mirrors, automotive electronics, and non-automatic-dimming rearview mirrors for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, automotive suppliers, and various aftermarket and accessory customers.
See Also
- Five stocks we like better than Gentex
- Overbought Stocks Explained: Should You Trade Them?
- Intel: Is Now the Time to Be Brave?Â
- The Most Important Warren Buffett Stock for Investors: His Own
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Gentex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gentex and related companies with MarketBeat.com's FREE daily email newsletter.